Loading this company
Aurobindo Pharma Limited
AUROPHARMA.NSPrices in INR
TickerWorth ScoreB61/100
What we think
Priced within our range of ₹944.61 to ₹2,299.58.
Price
₹1,621.40INR down −₹45.50 (−2.73%)
Quoted · Prices are delayed.
Showing the last price we hold for this listing, recorded 2026-10-19 13:20 UTC (5 hours ago).
Why did it move today?
Nothing we can cite explains today’s move for this company.
Is it cheap?
Our range from 3 models, on today’s numbers
₹944.61–₹2,299.58
What the price needs: revenue growth of 13.5%/yr for 5 years (our model assumes 10.1%).
Led by discounted cash flow (DCF) · Steady cash-flow business
Price ₹1,621.40Priced · Prices are delayed.
Is it a good business?
- Valuation67 out of 100
- Growth100 out of 100
- Financial health100 out of 100
- Dividend75 out of 100
- Past performance100 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
Analysts’ mean target
₹1,747.70 across 27 analysts
The high and low of the analyst range is part of Pro. See plans
What does it do?
Aurobindo Pharma Limited, a pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally. The company manufactures a range of finished formulation products in various forms, such as oral solids, liquids, injectables for generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients for CNS, anti-retroviral, cardiovascular, antibiotics, gastroenterology, anti-diabetics, and anti-allergic therapeutic areas. It operates in the Drug Manufacturers - Specialty & Generic industry (Healthcare sector), headquartered in India. The company employs roughly 29,209 people.
Key stats
52-week range₹1,080.10–₹1,740.00
- Open
- ₹1,662.10
- Day high
- ₹1,681.60
- Day low
- ₹1,615.60
- Previous close
- ₹1,666.90
- Volume
- 735,824 · 0.82× avg
- Average volume
- 898,472
- Market cap
- ₹932,917,805,056.00
- P/E (TTM)
- 25.33
- Earnings per share
- ₹64.00
- Beta
- 0.03
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
No filings or corporate activity on file in the recent window.
Top news
No recent headlines we can cite for this company.
Insider trades
No insider filings for this company in the recent window.
Not investment advice. TickerWorth Score is a model output.